Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.39%

Supernus Pharmaceuticals, Inc. (SUPN)

-NasdaqGM
8.56 Down 0.10(1.15%) 4:00PM EDT
Prev Close:8.66
Open:8.64
Bid:7.50 x 2000
Ask:9.12 x 800
1y Target Est:12.30
Beta:1.01
Next Earnings Date:11-Aug-14SUPN Earnings announcement
Day's Range:8.38 - 8.82
52wk Range:5.84 - 11.47
Volume:214,629
Avg Vol (3m):446,394
Market Cap:359.91M
P/E (ttm):N/A
EPS (ttm):-2.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SUPN

Comparison

Symbol% ChgMkt Cap
SUPNDown 1.15%359.91M
JNJDown 0.19%282.63B

Key Statistics

Forward P/E (1 yr):27.61
P/S (ttm):17.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.77
Quarterly EPS Est (Jun-14) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback